Nantahala Capital Management - FORTRESS BIOTECH INC ownership

FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 88 filers reported holding FORTRESS BIOTECH INC in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of FORTRESS BIOTECH INC
ValueSharesWeighting
Q3 2023$1,747,087
-50.3%
6,018,211
-5.8%
0.15%
-56.2%
Q2 2023$3,514,888
-38.0%
6,390,706
-7.6%
0.34%
-21.8%
Q1 2023$5,672,658
+8.7%
6,917,876
-13.2%
0.44%
+28.7%
Q4 2022$5,219,077
-26.6%
7,968,056
-3.6%
0.34%
-26.5%
Q3 2022$7,106,000
-3.4%
8,263,052
-5.7%
0.46%
+24.7%
Q2 2022$7,356,000
-38.8%
8,758,648
-0.9%
0.37%
-30.6%
Q1 2022$12,026,000
-47.1%
8,842,525
-2.7%
0.53%
-33.4%
Q4 2021$22,715,000
-13.3%
9,086,005
+11.6%
0.80%
-3.3%
Q3 2021$26,213,000
-2.5%
8,140,794
+8.1%
0.83%
+8.1%
Q2 2021$26,879,000
-11.5%
7,529,169
-12.5%
0.76%
-14.0%
Q1 2021$30,368,000
+10.4%
8,602,693
-0.9%
0.89%
+4.1%
Q4 2020$27,518,000
-17.2%
8,680,909
+5.5%
0.85%
-16.0%
Q3 2020$33,229,000
+180.2%
8,224,938
+85.9%
1.02%
+183.8%
Q2 2020$11,859,000
+243.1%
4,424,938
+142.0%
0.36%
+177.5%
Q1 2020$3,456,000
+230.1%
1,828,800
+349.1%
0.13%
+303.1%
Q4 2019$1,047,000
+120.4%
407,208
+21.0%
0.03%
+77.8%
Q3 2019$475,000336,6210.02%
Other shareholders
FORTRESS BIOTECH INC shareholders Q2 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,000,000$580,6000.19%
Nantahala Capital Management 6,018,211$1,747,0870.15%
THOMPSON DAVIS & CO., INC. 12,996$3,7730.01%
Platform Technology Partners 30,000$8,7090.00%
Black Maple Capital Management LP 15,000$4,3550.00%
Arete Wealth Advisors, LLC 52,547$15,2540.00%
B. Riley Wealth Advisors, Inc. 144,700$42,0060.00%
ACADIAN ASSET MANAGEMENT LLC 1,075,531$3110.00%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 1,542,000$447,6430.00%
GROUP ONE TRADING, L.P. 2,000$5810.00%
View complete list of FORTRESS BIOTECH INC shareholders